Board of Directors - Swedish Orphan

Mission, vision and background Values History Business Strategy Orphan drugs Human Resources Management Board of Directors

Home / About us / Board of Directors

	Rolf Classon Chairman since 2007 and Director since 2007Member of the remuneration committee and product committee. Other directorships: Hillenbrand Industries, Auxilium Pharmaceuticals, Millipore, Enzon Pharmaceuticals and PharmaNet Development.
	Claes Wilhelmsson Director since 2004 Member of the product committee. Other directorships: Director of Crucell N.V. and NMCT AB.
	Bo Jesper Hansen Managing Director and President Employed since 1994. Education: Registered physician, Doctor of medicine. Other directorships: Director of Vivolution A/S and Zymenex A/S.
	Thomas Eklund Director since 2004Managing Director Investor Growth Capital. Member of the audit committee. Other directorships: Director of Biotage AB (publ), Carmel Pharma AB, Memira AB, Neoventa Holding AB and Åmic AB, Deputy Director of Scibase AB.
	Louise Nilsson Director since 2004 Partner and Investment Manager Priveq Investment. Member of the remuneration committee and audit committee. Other directorships: Director of Bygg Partner AB, Innovativ Vision AB and The Swedish Private Equity & Venture Capital Association.
	Göran Pettersson Director since 2004 Member of the product committee. Other directorships: Director of Bringwell AB (publ), Cancer Targeting Technologies Oy and OxyPharma AB, Director of Recip AB.
	Per Olof Wallström Board member since 2004Member of the remuneration committee. Managing Director of Karo Bio AB (publ). Other directorships: Chairman of Arosgruppen Holding AB, Director of Karo Bio AB (publ) and Envirotainer Holding AB.